![]() |
But I find it totally ironic that these trades are unsuitable, but the use of daytrading instruments like the inverse and double-inverse and the double-long ETFs are beyond the purview of FINRA, even though they can often -- if not almost always -- be unsuitable for retail investors. In fact, it is a shame that today's UBS news obscures its courageous decision to ban these leveraged funds precisely because they are unsuitable for most of their investors. For UBS to take action that clearly hurts the bottom line -- these are wildly popular instruments -- says a lot more in its favor than any FINRA slap for unsuitability for certain closed-end funds. I hope people recognize that the stopping of trading of particular instruments that have hurt people is unbelievably courageous, as you know the uninformed customers who use these things are going to jump ship to other brokers. I wish FINRA would have noted when it fined UBS that the firm takes its commitment to the welfare of its customers very seriously, hence the withdrawal from trading these nefarious instruments. (If you want to know the whole story, read Don Dion's unbelievably good coverage.) UBS is a hero to me, regardless of the FINRA action. Now let's hope Merrill Lynch does the same. Maybe then the SEC will rethink its blessing of these products, a blessing that is specious in its reasoning -- as anyone who has read the letters the SEC knows -- because they rely on a theory that the market is too deep to manipulate and don't even touch on the notion that the instruments are indeed unsuitable for the vast majority of clients, who mistakenly believe that these are appropriate long-term hedges for existing positions. (For more on the debate, you should also read the work of Eric Oberg, who has articulated the issue well on our site.) At the time of publication, Cramer had no positions in the stocks mentioned.
Jim Cramer is co-founder and chairman of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. To order Cramer's newest book -- "Jim Cramer's Stay Mad for Life: Get Rich, Stay Rich (Make Your Kids Even Richer)," click here. Click here to order "Mad Money: Watch TV, Get Rich," click here to order "Real Money: Sane Investing in an Insane World," click here to get "You Got Screwed!" and click here for Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he appreciates your feedback and invites you to send comments by clicking here. TheStreet.com has a revenue-sharing relationship with Amazon.com under which it receives a portion of the revenue from Amazon.com purchases by customers directed there from TheStreet.com. Brokerage Partners
|
|||||||||||||||||||||||||||||||||||||||||